Cargando…
Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment
(1) Background: Analysis of tumor DNA by next-generation sequencing (NGS) plays various roles in the classification and management of cancer. This study aimed to assess the performance of two similar and large, comprehensive gene panels with a focus on clinically relevant variant detection and tumor...
Autores principales: | Ottestad, Anine Larsen, Huang, Mo, Emdal, Elisabeth Fritzke, Mjelle, Robin, Skarpeteig, Veronica, Dai, Hong Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863125/ https://www.ncbi.nlm.nih.gov/pubmed/36675703 http://dx.doi.org/10.3390/jpm13010042 |
Ejemplares similares
-
Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
por: Ottestad, Anine Larsen, et al.
Publicado: (2023) -
Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
por: Ottestad, Anine Larsen, et al.
Publicado: (2023) -
The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021) -
Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021) -
Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients
por: Mjelle, Robin, et al.
Publicado: (2019)